Enhanced Steroid Therapy in Adult Minimal Change Nephrotic Syndrome: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Enhanced Steroid Therapy in Adult Minimal Change Nephrotic Syndrome: A Systematic Review and Meta-analysis

Published:2015 Issue:17 Volume:54 Page:2101-2108
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Zhao Lingfei¹,Cheng Jun¹,Zhou Jingyi¹,Wu Congcong¹,Chen Jianghua¹

Affiliation:

1. Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, China

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/54/17/54_54.3927/_pdf

Reference35 articles.

1. 1. Broyer M, Meyrier A, Niaudet P, Habib R. Minimal changes and focal segmental glomerular sclerosis. In: Oxford Textbook of Clinical Nephrology. Vol. 1. Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E, Eds. Oxford University Press, Oxford, 1992: 298-339.

2. 2. Nachman PH, Jennette JC, Falk RJ. Primary glomerular diseases. In: Brenner and Rector's The Kidney. 8th Ed. Brenner BM, Ed. W.B. Saunders, Philadelphia, 2008: 995-1000.

3. 3. Bonilla-Felix M, Parra C, Dajani T, et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int 55: 1885-1890, 1999.

4. 4. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fuijimi S. Corticosteroid responsiveness and frequency of relapse in adult-incipient minimal change nephrotic syndrome. Am J Kidney Dis 39: 503-512, 2002.

5. 5. Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445-453, 2007.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal Change Disease and Focal Segmental Glomerulosclerosis in Adults;Evidence‐Based Nephrology;2022-11-18

2. Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date;Current Pediatric Reviews;2022-11

3. A randomised controlled unblinded multicentre non-inferiority trial with activated vitamin D and prednisolone treatment in patients with minimal change nephropathy (ADAPTinMCN);Trials;2021-07-12

4. Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome;Clinical and Experimental Nephrology;2020-10-22

5. A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report;BMC Nephrology;2020-09-29